Search

everythinglearnresearchcommunity

for

Search:↓

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Keratin treatment reduces astrocyte reactivity and inflammation.

Kalya Research is an AI tool that effectively finds and analyzes alternative medicine literature, saving researchers time.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Hinokitiol and pantothenylethylether in hair products can cause strong allergic reactions.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Different versions of the KRTAP6-2 gene in goats can lead to thinner cashmere fibers.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

The human keratin 6a gene's specific sequences trigger expression in skin layers after injury.

The guidelines recommend effective systemic treatments for alopecia areata in Korea.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

L-threonate may help prevent balding by blocking a key protein.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

COX-2 levels change during the hair cycle and affect skin and hair growth.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.